An integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH
An integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH
批准号:
10820048
负责人:
ERIC S DAAR
金额:
$102.59万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-24 至 2028-04-30
关键词:
AddressAdherenceAdultAnnual ReportsAnti-Retroviral AgentsAreaBehavioralCaringCase ManagerClinicComplexCountyDetectionDisparityDoseEpidemicEvaluationEventEvolutionFDA approvedFailureFeedbackFrequenciesGeographyGoalsHIVHIV InfectionsHIV diagnosisHomelessnessHot SpotIncentivesInequityInformation TechnologyInterventionLifeLos AngelesMeasurementMeasuresMonitorOutcomeParticipantPathway interactionsPatient Self-ReportPatientsPatternPersonsPharmaceutical PreparationsPlasmaPovertyProteusPublicationsRNARandomizedRecording of previous eventsReportingResearchRiskRunningSex BehaviorSexual PartnersSexually Transmitted DiseasesSocial WorkersSpecific qualifier valueSubstance Use DisorderSyphilisSystemTeam NursingTestingText MessagingTimeUpdateValidationViralViral Load resultWomanage groupagedantiretroviral therapyarmco-infectioncohortdigital healthefficacy evaluationempowermentfollow-upfood insecurityhealth determinantshigh riskhigh risk sexual behaviorhousing instabilityimprovedinnovationintervention programlongitudinal designmethamphetamine usemultidisciplinarynew technologypatient populationpillpost interventionprimary endpointpublic health relevancereal time monitoringrecruitresponsesafety netsecondary endpointsensorsensor technologysexual HIV transmissionsocialsocial stigmasynergismtherapy developmenttransmission processtreatment as usualusual care armyoung man
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Undetectable equals Untransmittable (U=U) reduces HIV stigma, empowers people living with HIV (PLWH), and
has become a pillar in the goal of ending the HIV epidemic. Viral suppression eliminating risk of sexual HIV
transmission emphasizes the importance of adherence to antiretroviral therapy (ART). Strategies to enhance
adherence have typically not intervened in real-time and have focused on pill-taking reminders without
interventions that address adverse social and behavioral determinants of health (SBDOH) associated with poor
adherence and engagement in care. The complex multifactorial pathways of SBDOH, such as food insecurity,
unstable housing, and substance use disorders, have led to inequities in achieving optimal adherence and
sustained viral suppression. Los Angeles (LA) County, a hot spot for HIV infection and transmission, has been
reported to have viral suppression rates of ~60%, well below the 95% target of Ending HIV Epidemic by 2030.
Our team has an extensive track record of research on measurement of and interventions to enhance adherence
to ART. We have used novel technology-based adherence measures of ART developed in the past two decades,
including the cutting-edge ingestible sensor (IS) technology to obtain non-inferred, real-time adherence
monitoring by Proteus® Digital Health Feedback (PDHF) system. Despite its validation reported in our recent
publications, the PDHF system has been limited by the lack of incorporation of SBDOH. For many years, a major
focus in HIV clinics has been to have multidisciplinary teams of nurses, social workers, and case managers to
address SBDOH; however, timing of interventions are often weeks to months after such problems have been
identified. This study will develop and test an integrated intervention that combines IS technology and adverse
SBDOH alerts to maximize adherence and viral suppression. Using real-time IS monitoring, our integrated
intervention will be able to immediately trigger the existing multidisciplinary team at clinic to address SBDOH
issues as soon as predefined patterns of poor adherence are observed. A cohort of 110 adult patients who have
or are at high risk for sub-optimal adherence will be recruited from a LA County safety net HIV clinic, located in
a geographic HIV hotspot, dealing many adverse SBDOH issues. Participants will be randomized into the
intervention or usual care. The integrated intervention will run for 20 weeks, followed by a 10-week period to
assess sustainability. The primary end points include acceptability of the integrated intervention, frequency and
timeliness of SBDOH interventions, level of challenges of SBDOH in HIV treatment, and adherence to ART. The
secondary end points include viral load, high-risk sexual activity defined by self-report, and detection of sexually
transmitted infections. The overarching goals are to evaluate (i) acceptability of the integrated intervention,
frequency and timeliness of SBDOH intervention, and level of challenges of SBDOH in HIV treatment; (ii) the
efficacy of the integrated intervention for monitoring, facilitating, and improving adherence to ART; and (iii) the
efficacy of the integrated intervention for improving virologic outcome and reducing high-risk sexual activity.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
-
批准号:9148267
-
项目类别:
-
资助金额:$87.95万
-
财政年份:2015
-
负责人:ERIC S DAAR
-
依托单位:
Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
-
批准号:9751390
-
项目类别:
-
资助金额:$67.98万
-
财政年份:2015
-
负责人:ERIC S DAAR
-
依托单位:
CLINICAL TRIAL: A PHASE III COMPARATIVE STUDY OF THREE NON-NUCLEOSIDE REVERSE TR
-
批准号:8174519
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
CLINICAL TRIAL: A PHASE IIIB, RANDOMIZED, TRIAL OF OPEN-LABEL EFAVIRENZ OR ATAZA
-
批准号:8174517
-
项目类别:
-
资助金额:$17.56万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
CALIFORNIA NEUROAIDS TISSUE NETWORK (CNTN)
-
批准号:8174523
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
CALIFORNIA NEURO AIDS TISSUE NETWORK
-
批准号:8174472
-
项目类别:
-
资助金额:$10.07万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
A LONGITUDINAL STUDY OF CEREBRAL AND NEUROCOGNITIVE FUNCTION
-
批准号:8174499
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO
-
批准号:8174485
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2009
-
负责人:ERIC S DAAR
-
依托单位:
CALIFORNIA NEURO AIDS TISSUE NETWORK
-
批准号:7952217
-
项目类别:
-
资助金额:$12.11万
-
财政年份:2008
-
负责人:ERIC S DAAR
-
依托单位:
A LONGITUDINAL STUDY OF CEREBRAL AND NEUROCOGNITIVE FUNCTION
-
批准号:7952267
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2008
-
负责人:ERIC S DAAR
-
依托单位:
A PHASE II/III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIA
-
批准号:7952242
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2008
-
负责人:ERIC S DAAR
-
依托单位:
LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO
-
批准号:7952244
-
项目类别:
-
资助金额:$6.36万
-
财政年份:2008
-
负责人:ERIC S DAAR
-
依托单位:
CALIFORNIA NEURO AIDS TISSUE NETWORK
-
批准号:7606162
-
项目类别:
-
资助金额:$1.7万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
A PHASE III, RANDOMIZED, OPEN-LABEL, COMPARISON OF LOPINAVIR/RITONAVIR PLUS E
-
批准号:7606178
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
CALIFORNIA NEURO - AIDS TISSUE NETWORK
-
批准号:7606125
-
项目类别:
-
资助金额:$4.58万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
PATHOGENESIS OF PRIMARY HIV INFECTION
-
批准号:7606123
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
THE SETPOINT STUDY - A RANDOMIZED STUDY OF THE EFFECT OF IMMEDIATE TREATMENT
-
批准号:7606118
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
ACUTE HIV INFECTION AND EARLY DISEASE RESEARCH PROGRAM (AIEDRP)
-
批准号:7606138
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
LONG-TERM METABOLIC ASSESSMENTS IN SUBJECTS TREATED WITH EMTRICITABINE/TENOFO
-
批准号:7606202
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2007
-
负责人:ERIC S DAAR
-
依托单位:
ACUTE HIV INFECTION AND EARLY DISEASE RESEARCH PROGRAM (AIEDRP)
-
批准号:7376029
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2005
-
负责人:ERIC S DAAR
-
依托单位:
海外基金